140 related articles for article (PubMed ID: 9067584)
1. Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma.
Martinez-Delgado B; Fernandez-Piqueras J; Garcia MJ; Arranz E; Gallego J; Rivas C; Robledo M; Benitez J
Leukemia; 1997 Mar; 11(3):425-8. PubMed ID: 9067584
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas.
Martinez-Delgado B; Robledo M; Arranz E; Osorio A; García MJ; Echezarreta G; Rivas C; Benitez J
Leukemia; 1998 Jun; 12(6):937-41. PubMed ID: 9639423
[TBL] [Abstract][Full Text] [Related]
3. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.
Villuendas R; Sánchez-Beato M; Martínez JC; Saez AI; Martinez-Delgado B; García JF; Mateo MS; Sanchez-Verde L; Benítez J; Martínez P; Piris MA
Am J Pathol; 1998 Sep; 153(3):887-97. PubMed ID: 9736037
[TBL] [Abstract][Full Text] [Related]
4. Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas.
Baur AS; Shaw P; Burri N; Delacrétaz F; Bosman FT; Chaubert P
Blood; 1999 Sep; 94(5):1773-81. PubMed ID: 10477703
[TBL] [Abstract][Full Text] [Related]
5. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.
Pinyol M; Cobo F; Bea S; Jares P; Nayach I; Fernandez PL; Montserrat E; Cardesa A; Campo E
Blood; 1998 Apr; 91(8):2977-84. PubMed ID: 9531609
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation and protein expression of the p16 gene: analysis of 43 cases of B-cell primary gastric lymphomas from China.
Huang Q; Ai L; Zhang ZY; Fan CY; Weiss LM
Mod Pathol; 2004 Apr; 17(4):416-22. PubMed ID: 14976529
[TBL] [Abstract][Full Text] [Related]
7. Frequent deletion and 5' CpG island methylation of the p16 gene in primary malignant lymphoma of the brain.
Zhang SJ; Endo S; Ichikawa T; Washiyama K; Kumanishi T
Cancer Res; 1998 Mar; 58(6):1231-7. PubMed ID: 9515810
[TBL] [Abstract][Full Text] [Related]
8. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
9. Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas.
García MJ; Martínez-Delgado B; Cebrian A; Martínez A; Benítez J; Rivas C
Am J Pathol; 2002 Sep; 161(3):1007-13. PubMed ID: 12213729
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of P16ink4a and P15ink4b genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas.
Martinez-Delgado B; Richart A; García MJ; Robledo M; Osorio A; Cebrian A; Rivas C; Benitez J
Br J Haematol; 2000 Apr; 109(1):97-103. PubMed ID: 10848787
[TBL] [Abstract][Full Text] [Related]
14. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
Martinez-Delgado B; Melendez B; Cuadros M; Jose Garcia M; Nomdedeu J; Rivas C; Fernandez-Piqueras J; Benítez J
Int J Cancer; 2002 Nov; 102(1):15-9. PubMed ID: 12353228
[TBL] [Abstract][Full Text] [Related]
15. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
16. Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas.
Gombart AF; Morosetti R; Miller CW; Said JW; Koeffler HP
Blood; 1995 Aug; 86(4):1534-9. PubMed ID: 7632961
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
Fosmire SP; Thomas R; Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Smith TL; Gardner LA; Ritt MG; Bell JS; Freeman KP; Greenfield BE; Lana SE; Kisseberth WC; Helfand SC; Cutter GR; Breen M; Modiano JF
Vet Pathol; 2007 Jul; 44(4):467-78. PubMed ID: 17606508
[TBL] [Abstract][Full Text] [Related]
18. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas.
Neumeister P; Hoefler G; Beham-Schmid C; Schmidt H; Apfelbeck U; Schaider H; Linkesch W; Sill H
Gastroenterology; 1997 Jun; 112(6):1871-5. PubMed ID: 9178679
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the p16 gene in nasopharyngeal carcinoma.
Lo KW; Cheung ST; Leung SF; van Hasselt A; Tsang YS; Mak KF; Chung YF; Woo JK; Lee JC; Huang DP
Cancer Res; 1996 Jun; 56(12):2721-5. PubMed ID: 8665502
[TBL] [Abstract][Full Text] [Related]
20. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
